Time and productivity loss associated with immunotherapy infusions for the treatment of melanoma in the United States: a survey of health care professionals and patients

• Main Authors: Raquel Aguiar-Ibáñez (Author), Emilie Scherrer (Author), Dmitri Grebennik (Author), John Cook (Author), Shalini Bagga (Author), Baanie Sawhney (Author), Anvi Khandelwal (Author), Scott A. Soefje (Author)
• Format: Book
• Published: BMC, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction A new dosing schedule for the oncology immunotherapy pembrolizumab, every 6 weeks (Q6W), has been approved by the U.S. FDA, reducing the frequency of visits to infusion centers. We quantified the time spent by oncologists, nurses, patients, and caregivers per melanoma-related i...